This study demonstrates that modest elevations in TDP-43 expression can trigger neurodegeneration and clinical phenotypes of ALS, suggesting that modestly elevated TDP-43 levels in humans could cause ALS and other neuromuscular disorders involving TDP-43 proteinopathy. Here, TARDBP is linked to proteostasis deficiencies.